Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025
- IVD Trends to Watch: Artificial intelligence (AI) Use in U.S. Liquid Biopsy Market December 3, 2024
- South Korea’s Healthcare Market: Medical Tourism and IVD Opportunities November 19, 2024
- IVDBO: Blood Screening Diagnostics 2024 Market Insights October 30, 2024
- IVD Trends to Watch: Coagulation Market to Reach $3.2 Billion and 920 Million Procedures in 2029 October 10, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Cell and Gene Therapy Investments Reach $5 Billion in Q1 2024, $35 Billion Total in 2023
Don’t miss our webinar, Navigating the Future of Cell and Gene Therapy: Financial Landscape & Market Dynamics by Disease Type, on July 25, 2024, at 2:00 PM Eastern Time. Register today by clicking HERE. Cell and gene therapy (CGT) companies continue to draw significant investments, although annual funding has decreased from over $70 billion in 2021 […]
IVD Trends to Watch: The Evolution of Point-of-Care (POC) Diagnostic Testing
In 2023, point-of-care (POC) diagnostic testing market sales reached $36.8 billion, fueled by both professional and self-testing, according to Kalorama Information’s April 2024 report The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. The POC diagnostic testing market continues to expand thanks to emerging technologies and increasing demand that will drive growth into the […]
IVD Trends to Watch: AI and the Future of Digital Pathology
Artificial intelligence (AI) is growing at a fast pace due to the adoption of AI-based technologies. There is a move toward connected health, which includes AI. AI has proved to be an invaluable tool in assisting physicians in caring for their patients. The advanced capabilities of algorithms are serving to reduce workloads and provide testing […]
Dynamic Landscape for Cell and Gene Therapy in 2024
2024 is an exciting time to be involved in the cell and gene therapy (CGT) industry. With rapid advancements in science, the industry is on the cusp of industrializing and standardizing the manufacturing and commercialization of CGT products. The future points toward standardized setups and more automated systems. However, the broad nature of the field […]
How Market Research Supercharges Laboratory Diagnostics Go-To-Market Strategies
In the dynamic laboratory diagnostics industry, staying ahead means having smart strategies in place. Market research is the secret ingredient that fuels successful go-to-market (GTM) plans. It helps you understand your audience, outshine competitors, and make informed decisions. In this blog, we explore how market research supercharges different parts of your GTM strategy for success […]
4 Key Components to a Winning Go-To-Market Strategy
Crafting a successful go-to-market (GTM) strategy in the laboratory diagnostic industry requires strategic planning and meticulous execution. It’s more than just bringing a product to market—it’s about aligning your offering with market needs, targeting the right audience, and positioning your brand for success. In this blog, we explore the essential steps and strategies necessary to […]
Immunoassays: A $27 Billion Market of Intrigue and Opportunity
The global market for lab-based immunoassays, inclusive of both infectious disease and non-infectious disease analytes and instruments, reached $27 billion in 2023 and is forecast to experience modest growth in the foreseeable future. The findings are based on data published in In Vitro Diagnostics Business Outlook, 2024, a bi-monthly newsletter focused on global IVD products […]
IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth
In Egypt, like many other countries, the elderly population is growing rapidly, increasing at a rate of 5.1% annually, which is more than double the growth rate of the total population. This demographic shift, coupled with a large rural population requiring satellite care and mobile services, poses significant challenges for the healthcare system, according to […]
Momentum in Multiplex Testing for IVD
Diagnostic testing is now a cornerstone of healthcare, assisting physicians in diagnosing conditions and prescribing treatments. Demand for in vitro diagnostic (IVD) testing has remained strong across various segments, with sales generally increasing throughout 2023. Global IVD market sales surpassed $100 billion in 2023, according to In Vitro Diagnostic (IVD) Trends and Market Update: March […]
Defining the Molecular Point of Care (mPOC) Market in 2024
Defining the molecular point of care (mPOC) market is the first step in market-sizing this segment. The mPOC market refers to the use of molecular diagnostic tests at or near the patient’s location to enable rapid and actionable clinical decisions. These tests typically involve the detection of nucleic acids (DNA or RNA) from pathogens or […]